Psychiatry Excellence Profile picture
Jun 26 12 tweets 3 min read Read on X
Up to 40% reduction in depression risk has been observed with adherence to anti-inflammatory diets like the Mediterranean diet, according to the PREDIMED study.

Emerging research links dietary patterns to neuroinflammation, neurotransmitter synthesis, and gut–brain signalling.

Here’s what clinicians need to know about nutritional strategies in psychiatric care, from gut microbiota to therapeutic nutrients. 🧵👇Image
The Gut–Brain Axis and Mental Health

The GI tract hosts 100 trillion microbes influence mood, cognition, and stress regulation.

Disruptions (e.g., from a Western diet) are associated with depression and anxiety.

Some strains produce neurotransmitters (e.g., serotonin precursors).
Dysbiosis and Psychiatric Risk

Animal studies show anxiety-like behavior after gut microbiota disruption (e.g., Campylobacter jejuni).

Probiotic foods like yoghurt, kefir, kimchi, and sauerkraut have shown promise in reducing gut inflammation and improving mood symptoms.

Clinical translation is ongoing.
A Shared Pathway

Depression is increasingly linked to low-grade systemic inflammation and oxidative stress.

• High-fat, high-sugar diets: ↑ TNF-α, IL-6

• Polyphenol-rich diets: ↑ BDNF, ↓ oxidative damage

This supports a neuroimmune model of affective disorders.
Anti-Inflammatory Dietary Models

• Mediterranean diet associated with ~30–40% ↓ risk of depression (PREDIMED study, 2013)

• Emphasis on whole grains, legumes, fish, olive oil, and vegetables

• Traditional Japanese and Norwegian diets show similar patterns Image
Nutrient Cofactors in Neurotransmission

• Tryptophan → serotonin (B6, folate, zinc dependent)

• Tyrosine → dopamine (requires vitamin C, Mg)

Zinc and L-methylfolate have been effective as adjuncts in TRD in several studies.
Ketogenic Diet and Psychiatry

Evidence (early-stage) supports keto’s use in TRD, bipolar disorder, and schizophrenia.

Mechanisms include:

• Ketone-mediated anti-inflammation (via BHB)

• ↑ GABA, ↓ glutamate

• Enhanced mitochondrial efficiency Image
Clinical Caveats of Ketogenic Diets

● Short-term risks: nausea, leg cramps

● Long-term: ↑ cholesterol, ↓ bone density

● Contraindicated in: type 1 diabetes, fatty acid oxidation disorders

Requires multidisciplinary oversight and ongoing monitoring.
RCT Evidence on Diet and Mood

• SMILES trial: dietary intervention ↓ for depressive symptoms (Cohen’s d = 1.1)

• PREDIMED: Mediterranean diet ↓ depression risk

Effect sizes rival pharmacotherapy—underscoring the value of integrated approaches.
Clinical Guidelines (RANZCP 2020)

Recommendations include:

• Whole foods > processed

• Prioritise sustainability and variety

• Consider gut-targeted strategies (probiotics, prebiotics)

• Tailor for adherence, comorbidity, and cultural preference
Take-Home For Clinicians

Nutrition affects neuroinflammation, cognition, and emotional regulation.

Not a substitute for psychiatric treatment—but a low-risk adjunct worth exploring.

Screen for diet quality, nutrient deficiencies, and refer as needed.
Want structured, evidence-based updates in psychiatry delivered to your inbox?

Join 23,000+ clinicians who receive expert commentary, diagnostic frameworks, and actionable clinical insights through the Psych Scene newsletter.

psychscene.co/42kdxsP

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Psychiatry Excellence

Psychiatry Excellence Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @psycheureka

Jun 25
Which patients with schizophrenia are at the highest risk of suicide?

In a 3-year pan-European study of 8,871 outpatients, the suicide attempt rate was 4.3%, with key predictors including prior attempts, depressive symptoms, prolactin-related side effects, male gender, and prior hospitalisation.

1/12 🧵Image
Lifetime suicide attempts increased future risk nearly fivefold (OR: 5.2), and suicide attempts in the 6 months prior raised risk 3.7× compared to none.

This finding reinforces the need for detailed longitudinal histories.

2/12 🧵
For every 1-point increase on the CGI-SCH depression subscale, suicide risk rose by 15.8% (OR: 1.158; p = 0.0015).

This underscores the link between affective symptoms and suicidal behaviour in schizophrenia.

3/12 🧵
Read 12 tweets
Jun 23
Over 50% of psychotropic medications are metabolised by CYP450 enzymes, many of which are genetically polymorphic.

This genetic variability explains why individuals differ significantly in drug response, tolerability, and plasma levels.

Here’s what you need to know about CYP pathways, phenotypes, clinical indications, and how to integrate testing into psychiatric practice. 🧵👇Image
What Is Pharmacogenomics?

Pharmacogenomics examines how genetic variation influences drug metabolism, receptor activity, and transport.

It informs dose adjustment, medication selection, and risk stratification, especially in psychotropics. (Hicks et al., 2015; Foulds et al., 2016)
CYP450 Enzymes in Psychiatry

CYP450 enzymes govern phase I metabolism for most psychotropics.

Clinically relevant isoenzymes:

• CYP2D6

• CYP2C19

• CYP1A2

• CYP3A4

Allelic variants produce poor, intermediate, normal, or ultra-rapid metaboliser phenotypes. Image
Read 8 tweets
Jun 21
Can probiotics reduce neuroinflammation in autism?

A small 2018 RCT in Egypt (Shaaban et al.) found autistic children taking probiotics had ~66% lower plasma myeloperoxidase (MPO) levels than those not on probiotics (1054 vs. 3161 pg/mL; p = 0.0009).

Findings are promising, but not yet generalisable.

1/13 🧵Image
MPO is a marker of neutrophil-driven inflammation.

It catalyses the formation of hypochlorous acid (HOCl), a reactive species linked to tissue damage and oxidative stress.

2/13 🧵
Increased MPO is found across multiple psychiatric conditions—schizophrenia, bipolar disorder, and autism spectrum disorder (ASD)—highlighting a shared neuroimmune link.

3/13 🧵
Read 13 tweets
Jun 17
An EEG study reveals that individuals with ADHD exhibit increased theta and alpha power, coupled with decreased beta power, indicating impaired attention regulation and executive control (Michelini, 2022).

These patterns reflect the same brain dynamics underlying overthinking: intrusive, uncontrolled, and cognitively taxing thought loops.

1/11🧵Image
Overthinking is not a diagnosis, but a symptom that crosses diagnostic boundaries.

In ADHD, anxiety, depression, PTSD, and bipolar disorder, it can signal cognitive dysregulation within core brain networks.

2/11 🧵
At its core, overthinking reflects a breakdown in executive function.

This includes impaired set-shifting, poor attention control, and inability to suppress intrusive thoughts, hallmarks of prefrontal–striatal–limbic dysfunction.

3/11 🧵
Read 11 tweets
Jun 16
Over 46% of the population carries the DRD2 A1 allele, which is linked to lower dopamine receptor density and increased risk of impulsive and compulsive behaviours (Blum et al., 2022).

Blum et al. (1995) found it could predict Reward Deficiency Syndrome behaviours, such as substance use and overeating, with up to 74.4% accuracy.

How does this genetic profile shape behaviour?Image
RDS is not a single disorder.

It’s a transdiagnostic spectrum of addictive, impulsive, and compulsive behaviours driven by hypodopaminergia—low tonic dopamine tone in mesolimbic circuits.

The phenotype may vary, such as substance use, gambling, and overeating, but the dopaminergic dysfunction is often shared.
At the core lies a disrupted reward cascade.

Risk alleles, early stress, and neurotoxins reduce dopamine transmission in the ventral tegmental area–nucleus accumbens pathway.

Behaviour shifts toward seeking short-term dopamine spikes to compensate for this deficit.

3/13 🧵
Read 13 tweets
Jun 12
Cognitive impairment is present in up to 80% of patients with schizophrenia, affecting attention, memory, and executive function (Saperstein & Kurtz, 2013).

These deficits are central, not peripheral, to functional outcomes.

Here's what clinicians need to know about diagnosis, monitoring, and treatment based on updated schizophrenia guidelines.👇🧵Image
Metabolic and Prolactin Monitoring

Guidelines recommend considering baseline and regular monitoring for:

• Metabolic parameters

• Prolactin levels

• Extrapyramidal symptoms

• Cognitive status

Failure to monitor contributes to treatment resistance and poor adherence.
Consider Matching Antipsychotics to Symptom Domains

• For predominant negative symptoms: Consider agents like cariprazine

• For acute agitation: Short-term use of fast-acting antipsychotics or benzodiazepines may be beneficial

• For prolactin elevation: Consider switching to aripiprazole

Matching drug profile to symptom burden may optimise outcomes.
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(